![Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. - Abstract - Europe PMC Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6591006/bin/fx1.jpg)
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. - Abstract - Europe PMC
![NMR Shows Hydrophobic Interactions Replace Glycine Packing in the Triple Helix at a Natural Break in the (Gly-X-Y)n Repeat* - Journal of Biological Chemistry NMR Shows Hydrophobic Interactions Replace Glycine Packing in the Triple Helix at a Natural Break in the (Gly-X-Y)n Repeat* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3e067151-3655-48b9-ae4c-6cc102efdbb6/gr1.jpg)
NMR Shows Hydrophobic Interactions Replace Glycine Packing in the Triple Helix at a Natural Break in the (Gly-X-Y)n Repeat* - Journal of Biological Chemistry
Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors | Journal of Medicinal Chemistry
![Systematic Review of Functional Outcomes in Cancer Rehabilitation - Archives of Physical Medicine and Rehabilitation Systematic Review of Functional Outcomes in Cancer Rehabilitation - Archives of Physical Medicine and Rehabilitation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8beee31c-1f54-4b03-80b6-4f089fc3f7de/gr1.jpg)
Systematic Review of Functional Outcomes in Cancer Rehabilitation - Archives of Physical Medicine and Rehabilitation
![Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 | Nature Medicine Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-018-0042-6/MediaObjects/41591_2018_42_Fig1_HTML.jpg)
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 | Nature Medicine
![PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization | Arteriosclerosis, Thrombosis, and Vascular Biology PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/e133c0f0-fb95-4354-ab24-6b72e6ca5db4/atvbaha.120.315168.fig06.jpg)
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization | Arteriosclerosis, Thrombosis, and Vascular Biology
![Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope - ScienceDirect Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761319301943-gr4.jpg)
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope - ScienceDirect
![Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure - Journal of Cardiac Failure Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure - Journal of Cardiac Failure](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/adafd564-8710-4d58-9380-b3dce5637078/gr1.jpg)
Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure - Journal of Cardiac Failure
![A naturally arising broad and potent CD4-binding site antibody with low somatic mutation | Science Advances A naturally arising broad and potent CD4-binding site antibody with low somatic mutation | Science Advances](https://www.science.org/cms/10.1126/sciadv.abp8155/asset/7503898c-f8aa-4f78-b491-25e8010f04a5/assets/images/large/sciadv.abp8155-f6.jpg)
A naturally arising broad and potent CD4-binding site antibody with low somatic mutation | Science Advances
![Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors | Journal of Medicinal Chemistry Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00315/asset/images/medium/jm1c00315_0014.gif)